$42.14 0.00 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Jul. 1, 2015 | 04:00 PM

Partner Headlines

  1. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  2. BioMarin, Sarepta Muscular Dystrophy Drugs Progress

    IBD | Jun. 29, 2015 | 10:18AM EST
  3. Biotech IPOs Steam Ahead Despite Fears Of Overload

    IBD | Jun. 23, 2015 | 08:02AM EST
  4. 5 NYSE Healthcare Stocks With The Highest ROE

    Benzinga | Jun. 22, 2015 | 09:29AM EST
  5. Jim Cramer Advises His Viewers On GlaxoSmithKline, American International Group, Caesars And Caesars Acquisition

    Benzinga | Jun. 18, 2015 | 07:12AM EST
  6. Billionaire George Soros Ups Two Stakes in First Quarter

    GuruFocus | Jun. 16, 2015 | 13:01PM EST
  7. Weekly 3-Year Low Highlights: GSK, TRP, NOV, CHK

    GuruFocus | Jun. 15, 2015 | 12:01PM EST
  8. Guru Stocks at 52-Week Lows: XOM, WMT, PG, CVX, GSK

    GuruFocus | Jun. 14, 2015 | 19:07PM EST
  9. Axovant IPO Best In 20 Years

    IBD | Jun. 11, 2015 | 18:56PM EST
  10. Axovant Sciences Sets 20-Year Record For Biotech IPOs

    IBD | Jun. 11, 2015 | 16:58PM EST
  11. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD | Jun. 11, 2015 | 12:58PM EST
  12. Will GlaxoSmithKline Cut Its 6% Dividend?

    GuruFocus | Jun. 3, 2015 | 15:32PM EST
  13. Perrigo buys Glaxo OTC drugs

    IBD | Jun. 2, 2015 | 18:40PM EST
  14. Will Perrigo's Glaxo Buy Make It Too Pricey?

    IBD | Jun. 2, 2015 | 13:08PM EST
  15. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  16. Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer

    GuruFocus | May. 22, 2015 | 18:21PM EST
  17. 9 International Dividend Dogs With Upside Potential

    GuruFocus | May. 22, 2015 | 16:48PM EST
  18. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  19. Tweedy Browne's Stocks With High Growing Yield

    GuruFocus | May. 11, 2015 | 18:39PM EST
  20. Kahn Brothers Ups Investment in 4 Stocks

    GuruFocus | May. 8, 2015 | 14:39PM EST
  21. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  22. IPO Stock Watch: Adaptimmune Upsizes But Stock Slips

    IBD | May. 6, 2015 | 17:20PM EST
  23. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  24. Isis Pharma Up As Bayer Licenses Thrombosis Drug

    IBD | May. 4, 2015 | 13:03PM EST
  25. GlaxoSmithKline

    IBD | Apr. 27, 2015 | 18:45PM EST
  26. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  27. Taking a Closer Look at GlaxoSmithKline

    GuruFocus | Apr. 22, 2015 | 12:37PM EST
  28. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  29. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  30. Dodge & Cox 2014 Equity Year in Review

    GuruFocus | Feb. 19, 2015 | 18:29PM EST
  31. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  32. Making Money With Charles Payne: 02/13/15

    FoxBusiness | Feb. 13, 2015 | 18:00PM EST
  33. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  34. Stocks Edge Higher Friday; Glaxo, Taiwan Semi Muscle Up

    IBD | Feb. 13, 2015 | 10:41AM EST
  35. Bestinfond's Top 5 New Buys During Q4

    GuruFocus | Feb. 3, 2015 | 16:15PM EST
  36. Mylan Makes Deals In Women's Health, Lung Disease

    IBD | Feb. 2, 2015 | 12:48PM EST
  37. Can GlaxoSmithKline Continue Striving in the Face of World Challenges?

    GuruFocus | Jan. 30, 2015 | 11:17AM EST
  38. GlaxoSmithKline Expands Its Portfolio Of Medicines In The US For Patients With Asthma And COPD

    Benzinga | Jan. 26, 2015 | 09:21AM EST
  39. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  40. Gilead Sciences Still has More Upside

    GuruFocus | Jan. 22, 2015 | 15:28PM EST
  41. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  42. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  43. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  44. Isis Pharma To Develop GI Drugs With J&J

    IBD | Jan. 5, 2015 | 13:17PM EST
  45. Pfizer, Home of Lipitor and Viagra, Lifts Dividend

    IBD | Dec. 31, 2014 | 17:16PM EST
  46. Ebola Drug Work Continues

    IBD | Dec. 26, 2014 | 18:22PM EST
  47. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  48. BioMarin CEO Sees Big Future For Prosensa Drug

    IBD | Dec. 23, 2014 | 16:11PM EST
  49. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus | Dec. 14, 2014 | 21:52PM EST
  50. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!